Circulating levels of inflammatory markers and mammographic density among postmenopausal women

Breast Cancer Research and Treatment

Volumn 127, Issue 2, 2011, Pages 555-563

  Reeves, Katherine W ^a,d   Weissfeld, Joel L ^b,c   Modugno, Francesmary ^b   Diergaarde, Brenda ^b,c  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d 410 Arnold House ^*  (United States)

Author keywords

C reactive protein (CRP); Interleukin 6 (IL 6); Mammographic density; Postmenopausal; Tumor necrosis factor (TNF )

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; BREAST BIOPSY; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MAMMOGRAPHY; MIDDLE AGED; POSTMENOPAUSE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79958201848     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1249-5     Document Type: Article

References (53)

1. NF Boyd LJ Martin JM Rommens, et al. 2009 Mammographic density: a heritable risk factor for breast cancer Methods Mol Biol 472 343 360 19107441 10.1007/978-1-60327-492-0-15
2. JN Wolfe 1976 Breast patterns as an index of risk for developing breast cancer Am J Roentgenol 126 1130 1137 1:STN:280:DyaE283gtlGrsw%3D%3D
3. JN Wolfe 1969 The prominent duct pattern as an indicator of cancer risk Oncology 23 149 158 5787935 10.1159/000224476 1:STN:280:DyaF1M3htlSmug%3D%3D
4. G Torres-Mejia B De Stavola DS Allen, et al. 2005 Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies Cancer Epidemiol Biomarkers Prev 14 1052 1059 15894652 10.1158/1055-9965.EPI-04-0717 (Pubitemid 40656447)
5. I Kato C Beinart A Bleich, et al. 1995 A nested case-control study of mammographic patterns, breast volume, and breast cancer Cancer Causes Control 6 431 438 8547541 10.1007/BF00052183 1:STN:280:DyaK28%2FlvVGjtQ%3D%3D
6. C Byrne C Schairer J Wolfe, et al. 1995 Mammographic features and breast cancer risk: effects with time, age, and menopause status J Natl Cancer Inst 87 1622 1629 7563205 10.1093/jnci/87.21.1622 1:STN:280:DyaK28%2Fis1aluw%3D%3D
7. NF Boyd GS Dite J Stone, et al. 2002 Heritability of mammographic density, a risk factor for breast cancer N Engl J Med 347 886 894 12239257 10.1056/NEJMoa013390
8. GA Greendale BA Reboussin S Slone, et al. 2003 Postmenopausal hormone therapy and change in mammographic density J Natl Cancer Inst 95 30 37 12509398 10.1093/jnci/95.1.30 1:CAS:528:DC%2BD3sXitlOnt74%3D (Pubitemid 36124293)
9. LM Morimoto E White Z Chen, et al. 2002 Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative Cancer Causes Control 13 741 751 12420953 10.1023/A:1020239211145 (Pubitemid 35204050)
10. JA Harvey JV Pinkerton CR Herman 1997 Short-term cessation of hormone replacement therapy and improvement of mammographic specificity J Natl Cancer Inst 89 1623 1625 9362162 10.1093/jnci/89.21.1623 1:STN:280: DyaK1c%2Fis1Crtw%3D%3D (Pubitemid 27479724)
11. G Ursin YR Parisky MC Pike, et al. 2001 Mammographic density changes during the menstrual cycle Cancer Epidemiol Biomarkers Prev 10 141 142 11219771 1:STN:280:DC%2BD3M3ksVGgtw%3D%3D (Pubitemid 32172433)
12. T Key P Appleby I Barnes, et al. 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies J Natl Cancer Inst 94 606 616 11959894 1:CAS:528:DC%2BD38Xjs1eit7w%3D (Pubitemid 34498648)
13. R Kaaks S Rinaldi TJ Key, et al. 2005 Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr Relat Cancer 12 1071 1082 16322344 10.1677/erc.1.01038 1:CAS:528:DC%2BD28XnvVyhsA%3D%3D (Pubitemid 41815798)
14. GK Reeves V Beral J Green, et al. 2006 Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis Lancet Oncol 7 910 918 17081916 10.1016/S1470-2045(06)70911-1 1:CAS:528:DC%2BD28XhtFKmt7bN (Pubitemid 44615945)
15. NR Shah J Borenstein RW Dubois 2005 Postmenopausal hormone therapy and breast cancer: a systematic review and meta-analysis Menopause 12 668 678 16278609 10.1097/01.gme.0000184221.63459.e1 (Pubitemid 41669118)
16. M Cotterchio N Kreiger M Sloan, et al. 2001 Nonsteroidal anti-inflammatory drug use and breast cancer risk Cancer Epidemiol Biomarkers Prev 10 1213 1217 11700271 1:CAS:528:DC%2BD3MXptFWqu7Y%3D (Pubitemid 33064311)
17. RE Harris RT Chlebowski RD Jackson, et al. 2003 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative Cancer Res 63 6096 6101 14522941 1:CAS:528: DC%2BD3sXnvVSitb8%3D (Pubitemid 37187516)
18. SA Khuder AB Mutgi 2001 Breast cancer and NSAID use: a meta-analysis Br J Cancer 84 1188 1192 11336469 10.1054/bjoc.2000.1709 1:CAS:528: DC%2BD3MXkt1Olurc%3D (Pubitemid 32511336)
19. MB Terry MD Gammon FF Zhang, et al. 2004 Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk JAMA 291 2433 2440 15161893 10.1001/jama.291.20.2433 1:CAS:528:DC%2BD2cXksVehurk%3D (Pubitemid 38669186)
20. L Gallicchio MA McSorley CJ Newschaffer, et al. 2006 Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease Cancer 106 1443 1452 16502408 10.1002/cncr.21763 1:CAS:528:DC%2BD28XjsFerurw%3D
21. RN DuBois 2004 Aspirin and breast cancer prevention: the estrogen connection JAMA 291 2488 2489 15161901 10.1001/jama.291.20.2488 1:CAS:528:DC%2BD2cXksVens70%3D (Pubitemid 38669194)
22. MJ Reed A Purohit 1997 Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis Endocr Rev 18 701 715 9331549 10.1210/er.18.5.701 1:CAS:528:DyaK2sXmslOnu74%3D (Pubitemid 27435541)
23. A Purohit MJ Reed 2002 Regulation of estrogen synthesis in postmenopausal women Steroids 67 979 983 12398994 10.1016/S0039-128X(02)00046-6 1:CAS:528:DC%2BD38XotVeqt74%3D (Pubitemid 35175465)
24. Carr BR, Bradshaw KD (2001) Disorders of the ovary and female reproductive tract. In: Braunwald E, Fauci AS, Kasper DL et al (eds) Harrison's principles of internal medicine, 15th edn. McGraw-Hill, New York, NY
25. P Bogaty JM Brophy M Noel, et al. 2004 Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study Circulation 110 934 939 15302800 10.1161/01.CIR. 0000139338.12464.5F 1:CAS:528:DC%2BD2cXms1Ogt7g%3D (Pubitemid 39128618)
26. D Il'yasova LH Colbert TB Harris, et al. 2005 Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort Cancer Epidemiol Biomarkers Prev 14 2413 2418 16214925 10.1158/1055-9965.EPI-05-0316 (Pubitemid 41437845)
27. K Heikkila R Harris G Lowe, et al. 2009 Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis Cancer Causes Control 20 15 26 18704713 10.1007/s10552-008-9212-z
28. D Bhandare R Nayar M Bryk, et al. 2005 Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer Cancer Epidemiol Biomarkers Prev 14 2620 2627 16284387 10.1158/1055-9965.EPI-05-0302 1:CAS:528:DC%2BD2MXhtlWhurfF (Pubitemid 41752724)
29. G Gonullu C Ersoy A Ersoy, et al. 2005 Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer Cytokine 31 264 269 15955709 10.1016/j.cyto.2005.05.003 1:CAS:528:DC%2BD2MXntVGhs74%3D (Pubitemid 41097362)
30. I Caras A Grigorescu C Stavaru, et al. 2004 Evidence for immune defects in breast and lung cancer patients Cancer Immunol Immunother 53 1146 1152 15185014 10.1007/s00262-004-0556-2 1:CAS:528:DC%2BD2cXotlKgtr0%3D (Pubitemid 39506403)
31. FG DeKeyser JM Wainstock L Rose, et al. 1998 Distress, symptom distress, and immune function in women with suspected breast cancer Oncol Nurs Forum 25 1415 1422 9766295 1:STN:280:DyaK1cvjvFCgsA%3D%3D
32. RA Krajcik S Massardo N Orentreich 2003 No association between serum levels of tumor necrosis factor-alpha (TNF-alpha) or the soluble receptors sTNFR1 and sTNFR2 and breast cancer risk Cancer Epidemiol Biomarkers Prev 12 945 946 14504210 1:CAS:528:DC%2BD3sXnsValtL8%3D (Pubitemid 37151534)
33. MJ Campbell J Scott HT Maecker, et al. 2005 Immune dysfunction and micrometastases in women with breast cancer Breast Cancer Res Treat 91 163 171 15868444 10.1007/s10549-004-7048-0 1:CAS:528:DC%2BD2MXjvVWjsr0%3D (Pubitemid 40684928)
34. SM Sheen-Chen WJ Chen HL Eng, et al. 1997 Serum concentration of tumor necrosis factor in patients with breast cancer Breast Cancer Res Treat 43 211 215 9150900 10.1023/A:1005736712307 1:STN:280:DyaK2s3psFamug%3D%3D (Pubitemid 27173956)
35. KH Allin SE Bojesen BG Nordestgaard 2009 Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer J Clin Oncol 27 2217 2224 19289618 10.1200/JCO.2008.19.8440 1:CAS:528: DC%2BD1MXlvFOgs7w%3D
36. SM Zhang J Lin NR Cook, et al. 2007 C-reactive protein and risk of breast cancer J Natl Cancer Inst 99 890 894 17551149 10.1093/jnci/djk202 1:CAS:528:DC%2BD2sXns1als7c%3D (Pubitemid 47073511)
37. D Trichopoulos T Psaltopoulou P Orfanos, et al. 2006 Plasma C-reactive protein and risk of cancer: a prospective study from Greece Cancer Epidemiol Biomarkers Prev 15 381 384 16492932 10.1158/1055-9965.EPI-05-0626 1:CAS:528:DC%2BD28Xhs1WrtLk%3D (Pubitemid 43348407)
38. C Siemes LE Visser JW Coebergh, et al. 2006 C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study J Clin Oncol 24 5216 5222 17114654 10.1200/JCO.2006.07.1381 1:CAS:528: DC%2BD28XhtlemurbO (Pubitemid 46631365)
39. D Lithgow A Nyamathi D Elashoff, et al. 2007 C-reactive protein in nipple aspirate fluid associated with Gail model factors Biol Res Nurs 9 108 116 17909163 10.1177/1099800407306426 1:CAS:528:DC%2BD2sXhtF2rsbjL
40. KW Reeves GL Gierach F Modugno 2007 Recreational physical activity and mammographic breast density characteristics Cancer Epidemiol Biomarkers Prev 16 934 942 17507619 10.1158/1055-9965.EPI-06-0732 (Pubitemid 46910095)
41. AG Hudson GL Gierach F Modugno, et al. 2008 Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women Cancer Epidemiol Biomarkers Prev 17 680 687 18349287 10.1158/1055-9965.EPI-07- 2739 1:CAS:528:DC%2BD1cXjtlKhsbc%3D (Pubitemid 351469220)
42. MR Palomares JR Machia CD Lehman, et al. 2006 Mammographic density correlation with Gail model breast cancer risk estimates and component risk factors Cancer Epidemiol Biomarkers Prev 15 1324 1330 16835331 10.1158/1055-9965.EPI-05-0689 (Pubitemid 44125289)
43. G Haars PA van Noord CH van Gils, et al. 2005 Measurements of breast density: no ratio for a ratio Cancer Epidemiol Biomarkers Prev 14 2634 2640 16284389 10.1158/1055-9965.EPI-05-0824 (Pubitemid 41752726)
44. NF Boyd LJ Martin L Sun, et al. 2006 Body size, mammographic density, and breast cancer risk Cancer Epidemiol Biomarkers Prev 15 2086 2092 17119032 10.1158/1055-9965.EPI-06-0345 (Pubitemid 44877030)
45. KW Reeves RA Stone F Modugno, et al. 2009 Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation Int J Cancer 124 1169 1177 19065651 10.1002/ijc.23996 1:CAS:528:DC%2BD1MXhvFCltrg%3D
46. Woolcott CG, Cook LS, Courneya KS et al (2010) Associations of overall and abdominal adiposity with area and volumetric mammographic measures among postmenopausal women. Int J Cancer. doi: 10.1002/ijc.25676
47. H Himmerich S Fulda J Linseisen, et al. 2006 TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population Eur Cytokine Netw 17 196 201 17194640 1:CAS:528:DC%2BD28Xht1ylu7zJ
48. M Bochud F Marquant PM Marques-Vidal, et al. 2009 Association between C-reactive protein and adiposity in women J Clin Endocrinol Metab 94 3969 3977 19584180 10.1210/jc.2008-2428 1:CAS:528:DC%2BD1MXht12ru7bE
49. SP Weisberg D McCann M Desai, et al. 2003 Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 1796 1808 14679176 1:CAS:528:DC%2BD3sXhtVSmtLvO (Pubitemid 38063703)
50. C Sunderkotter K Steinbrink M Goebeler, et al. 1994 Macrophages and angiogenesis J Leukoc Biol 55 410 422 7509844 1:STN:280:DyaK2c7msFGrsw%3D%3D (Pubitemid 24097250)
51. R Garcia-Macedo F Sanchez-Munoz JC Almanza-Perez, et al. 2008 Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells Eur J Pharmacol 587 317 321 18499099 10.1016/j.ejphar.2008.03. 051 1:CAS:528:DC%2BD1cXmsFGksrY%3D
52. U Kolsum K Roy C Starkey, et al. 2009 The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year Int J Chron Obstruct Pulmon Dis 4 149 156 19436686 1:CAS:528: DC%2BD1MXhsVCisrvP
53. M Karakas J Baumert S Greven, et al. 2010 Reproducibility in serial C-reactive protein and interleukin-6 measurements in post-myocardial infarction patients: results from the AIRGENE study Clin Chem 56 861 864 20299677 10.1373/clinchem.2010.143719 1:CAS:528:DC%2BC3cXlsFKgtLo%3D